Reported
Lowest–highest estimate
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Surgical Science Sweden AB
STO:SUS
Surgical Science Sweden AB
STO:SUS
Price:
51.25
SEK
2.83%
Market Cap:
kr2.6B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Surgical Science Sweden AB
STO:SUS
|
SE |
Wall St Price Targets
SUS Price Forecast
Based on 6 analysts
Based on 6 analysts
+22% Upside
from
kr51.25
today
Surgical Science Sweden AB (SUS)’s 12-month stock price forecast through September 2027 has a consensus target of kr62.73, implying 22% upside. The forecast is based on price targets from 6 Wall Street analysts.
SUS Analyst Rating
No ratings yet
No ratings yet
Surgical Science Sweden AB Competitors:
Price Targets
Price Targets
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is SUS's stock price target?
Price Target
62.73
SEK
62.73
SEK
According to Wall Street analysts, the average 1-year price target for SUS is 62.73 SEK with a low forecast of 60.6 SEK and a high forecast of 93.45 SEK.
What is the Revenue forecast for Surgical Science Sweden AB?
Projected CAGR
10%
10%
Over the last 10 years, the compound annual growth rate for Revenue has been 36%. The projected CAGR for the next 8 years is 10%.
What is the Gross Profit forecast for Surgical Science Sweden AB?
Projected CAGR
12%
12%
Over the last 10 years, the compound annual growth rate for Gross Profit has been 29%. The projected CAGR for the next 5 years is 12%.
What is the Operating Income forecast for Surgical Science Sweden AB?
Projected CAGR
30%
30%
Over the last 10 years, the compound annual growth rate for Operating Income has been 49%. The projected CAGR for the next 5 years is 30%.
What is the Pre-Tax Income forecast for Surgical Science Sweden AB?
Projected CAGR
34%
34%
Over the last 10 years, the compound annual growth rate for Pre-Tax Income has been 51%. The projected CAGR for the next 3 years is 34%.
What is the Net Income forecast for Surgical Science Sweden AB?
Projected CAGR
36%
36%
Over the last 10 years, the compound annual growth rate for Net Income has been 45%. The projected CAGR for the next 5 years is 36%.